PT-141 10 mg

Everything printed on your box must match the details above. If any line is different, stop and contact us before using the product.

• Peptide name printed on the box reads PT-141
• Strength reads 10 mg
• Batch number on the box matches the vial label
• Expiry date is printed and still valid
• Vial cap is sealed and has never been pierced
• Box shows the Synedica holographic seal

• 01 × Peptide vial

  Lyophilised powder, sealed under vacuum with flip-off cap.

• 01 × BAC water 3 ml

  Bacteriostatic water USP for reconstitution of the vial.

• 10 × 31G extra-fine insulin syringes

  Sterile, single-use, graduated for precise low volumes.

• 01 × 3 ml reconstitution syringe

  Used only to transfer the BAC water into the peptide vial.

• 10 × Isopropyl alcohol wipes

  70% IPA pads to sanitise vial stoppers and the work area.

• 01 × Sealed security box

  Holographic seal, scratch-off code panel and NFC chip.

Work on a clean surface, with clean hands, using only the sterile items supplied in your kit.

1. 1

   Prepare and sanitise

   Wash your hands, clear a flat surface and open one alcohol wipe. Clean the rubber stopper of both the peptide vial and the BAC water vial, then let them dry.

2. 2

   Draw the BAC water

   Using the 3 ml reconstitution syringe, draw the full 3 ml of bacteriostatic water from its vial.

3. 3

   Add the water slowly

   Insert the needle at an angle and let the water run down the inner glass wall — never spray it directly onto the powder, which can damage the peptide.

4. 4

   Dissolve without shaking

   Roll or swirl the vial gently between your fingers until the solution is completely clear. Never shake. Small bubbles are normal and settle on their own.

5. 5

   Label and refrigerate

   Write the reconstitution date on the vial and place it in the fridge. Discard the reconstitution syringe after this single use.

6. 6

   Withdraw with a fresh syringe

   For each withdrawal, wipe the stopper again and use a new sterile 31G insulin syringe. Never reuse a syringe or needle.

PT-141 (Bremelanotide) is a melanocortin-receptor agonist studied for its potential role in libido and sexual-function research pathways. It remains investigational and is not an approved treatment in this form.